2,3-Bis[(1-phenyl-1H-tetrazol-5-ylsulfanyl)methyl]quinoxaline

Abstract

The title compound, C24H18N10S2, crystallizes with two independent molecules in the asymmetric unit. The two terminal (1-phenyltetrazol-5-yl)sulfanyl groups adopt a trans configuration with respect to the central quinoxaline ring system in both independent molecules.